Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated β-catenin stabilization
SUPPLEMENTARY MATERIALS
Supplementary Figure 1: BAPTA inhibits PAR 2 -induced β-catenin stabilization levels and β-catenin transcriptional activity. (A) BAPTA inhibition of PAR 2 induced β-catenin levels. HU cells were transiently co-transfected with hPar2 and flg-β-catenin plasmids. At various time points after SLIGKV activation, cell lysates were prepared and analyzed for levels of β-catenin. Pretreatment (30 min or 1 h) of the cells with BAPTA and treatment during the activation periods showed potent inhibition in β-catenin levels. (B) BAPTA inhibition of PAR 2 -induced β-catenin transcriptional activity. TOPflash luciferase transcription activity was analyzed in HU cells following PAR 2 activation in the absence or presence of hPar2 wt following pretreatment of BAPTA (10-30 μM for 10 min prior to activation and following 5h or 6h SLIGKV activation). While following SLIGKV PAR 2 activation a marked increase in luciferase Lef/Tcf activity is observed (p<0.01), no increase was observed in the presence of BAPTA, where levels were similar to those of control non-activated PAR 2 . Results were evaluated using GraphPad InStat software. Immunoflorescence staining of DVL1. HEK-293T cells were transfected with flg-dvl1 and activated with thrombin for 5 h following pretreatment with leptomycin B (LMB), a nuclear export inhibitor. Detection was carried out using anti-flg antibodies and fluorescent Cy3-conugated anti-mouse antibodies. Cell nuclei were counter-stained with DAPI. Following PAR 1 activation, nuclear localization of DVL1 was observed. (C) Levels of nuclear DVL1 following application of LMB and PAR 1 activation. Western blot analysis of nuclear DVL1 in the presence of LMB and following PAR 1 activation. While PAR 1 activation instigated potent DVL1 nuclear localization, in the presence of LMB, which blocks the nuclear export process, there was a marked increase in nuclear DVL following PAR 1 activation. This is shown using lamin as a marker for nuclear protein levels. After PAR 1 activation, the nuclear fraction was prepared and immunoblots were analyzed using either anti-flg, anti-myc, or anti-lamin antibodies. The internalization of DVL to the nucleus was inhibited in the absence of the PDZ domain. The PDZ, but not the DIX domain, is necessary for PAR 1 induction of nuclear localization of DVL1. (C) Localization of PAR 1 and DVL1 in breast cancer tissue sections. Immunohistochemistry of paraffin-embedded breast tissue sections shows staining of both PAR 1 and DVL1 in the cytoplasm of breast cancer tissues, compared with very weak or no staining in normal-appearing tissue. In IDC, a very aggressive carcinoma, a massive straining of PAR 1 and DVL1 is observed in the cytoplasm as well as extensive expression of DVL in the nucleus. Data shown are representative of two independent experiments.
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